Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-19
2009-12-15
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S492000
Reexamination Certificate
active
07632829
ABSTRACT:
The invention is concerned with novel diazepan derivatives of formula (I)wherein A, X, R3, R4, R5, R6, R8, R9, R10, R11, R12, R13, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
REFERENCES:
patent: WO 03/022277 (2003-03-01), None
patent: WO 03/095029 (2003-11-01), None
patent: WO 2004/084898 (2004-10-01), None
patent: WO 2004/092124 (2004-10-01), None
patent: WO 2004/094371 (2004-11-01), None
patent: WO 2007/122104 (2007-11-01), None
Aebi Johannes
Green Luke
Mattei Patrizio
Ricklin Fabienne
Roche Olivier
Hoffmann-La Roche Inc.
Johnston George W.
Kifle Bruck
Tramaloni Dennis P.
LandOfFree
Diazepan derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazepan derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepan derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4123319